<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://thescriptpad.com/articles/kff-2026-employer-survey-family-premium-28303-worker-share-up-9-percent.html</loc><news:news><news:publication><news:name>The Script Pad</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-22T10:00:00-04:00</news:publication_date><news:title>Workers Now Pay $7,471 a Year for Family Coverage, Up 9 Percent. Here Is What KFF&#x27;s 2026 Survey Means for Your Front Desk.</news:title></news:news></url>
  <url><loc>https://thescriptpad.com/articles/acgme-proposes-12-hours-off-after-24-hour-call-comments-due-oct-22.html</loc><news:news><news:publication><news:name>The Script Pad</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-22T09:50:00-04:00</news:publication_date><news:title>ACGME Proposes 12 Hours Off After 24-Hour Call and Drops the Every-Third-Night Rule. Comments Close Oct. 22.</news:title></news:news></url>
  <url><loc>https://thescriptpad.com/articles/moderna-merck-intismeran-interpath-001-esmo-oct-24-melanoma-phase-3.html</loc><news:news><news:publication><news:name>The Script Pad</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-22T09:40:00-04:00</news:publication_date><news:title>Moderna and Merck Present Phase 3 Melanoma Data on Oct. 24. Here Is What to Look For in the Numbers.</news:title></news:news></url>
  <url><loc>https://thescriptpad.com/articles/cms-dol-employers-electronic-prior-authorization-self-funded-plans.html</loc><news:news><news:publication><news:name>The Script Pad</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-22T09:30:00-04:00</news:publication_date><news:title>Five Large Employers Back Electronic Prior Authorization for Self-Funded Plans. Their Statement Sets No Deadline.</news:title></news:news></url>
  <url><loc>https://thescriptpad.com/articles/mississippi-rural-health-transformation-32-million-physician-recruitment-psychiatric-emergency-units.html</loc><news:news><news:publication><news:name>The Script Pad</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-22T09:20:00-04:00</news:publication_date><news:title>Mississippi Gets $32 Million From the Rural Health Fund to Recruit Physicians and Open Three Psychiatric Emergency Units</news:title></news:news></url>
  <url><loc>https://thescriptpad.com/articles/fda-approves-bepirovirsen-hibsago-chronic-hepatitis-b-functional-cure.html</loc><news:news><news:publication><news:name>The Script Pad</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-21T10:00:00-04:00</news:publication_date><news:title>FDA Approves Bepirovirsen for Chronic Hepatitis B. In Phase 3, 19 Percent Reached Functional Cure Off Treatment.</news:title></news:news></url>
  <url><loc>https://thescriptpad.com/articles/aad-hs-foundation-first-joint-hidradenitis-suppurativa-guidelines-step-therapy.html</loc><news:news><news:publication><news:name>The Script Pad</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-21T09:50:00-04:00</news:publication_date><news:title>AAD and HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines. Step Therapy Is Named the Largest Barrier.</news:title></news:news></url>
  <url><loc>https://thescriptpad.com/articles/fda-final-guidance-prescription-drug-apps-software-labeling.html</loc><news:news><news:publication><news:name>The Script Pad</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-21T09:40:00-04:00</news:publication_date><news:title>FDA Finalizes Guidance on Prescription Drug Apps. Some Apps Now Belong in the Prescribing Information.</news:title></news:news></url>
  <url><loc>https://thescriptpad.com/articles/fda-approves-first-generic-climara-pro-weekly-hormone-patch.html</loc><news:news><news:publication><news:name>The Script Pad</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-21T09:30:00-04:00</news:publication_date><news:title>FDA Approves the First Generic of Climara Pro, a Once-Weekly Estradiol-Levonorgestrel Patch</news:title></news:news></url>
  <url><loc>https://thescriptpad.com/articles/annals-model-hepatitis-b-birth-dose-change-chronic-infections.html</loc><news:news><news:publication><news:name>The Script Pad</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-20T10:10:00-04:00</news:publication_date><news:title>Ending the Universal Hepatitis B Birth Dose Would Raise Chronic Infections by 19 to 83 Percent, a New Model Projects</news:title></news:news></url>
  <url><loc>https://thescriptpad.com/articles/fda-approves-dostarlimab-msi-h-dmmr-locally-advanced-rectal-cancer.html</loc><news:news><news:publication><news:name>The Script Pad</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-20T10:00:00-04:00</news:publication_date><news:title>FDA Approves Dostarlimab for MSI-H/dMMR Rectal Cancer. In AZUR-1, 47 Percent Had a Sustained Complete Response Without Surgery.</news:title></news:news></url>
</urlset>
